Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

In vitro telomere extension and proliferation culture method of chondrocytes and human tissue engineered regeneration of cartilage

A chondrocyte and telomere lengthening technology, applied in the field of cell biology, can solve the problems of inability to walk, affect the quality of life, pain, etc., achieve the improvement of safety and applicability, increase the activity of telomerase, and prolong the length of telomeres. Effect

Active Publication Date: 2019-11-08
BEIHAO STEM CELL & REGENERATIVE MEDICINE RES INST CO LTD +2
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Patients often feel pain and stiffness, and eventually develop into severe arthritis, or even be unable to walk, which seriously affects the quality of life
[0007] Since mature cartilage tissue is a tissue without nerves, blood vessels, and lymphatic vessels, and chondrocytes are sparsely distributed in cartilage tissue, the self-renewal speed of cartilage tissue is slow and the self-repair ability is limited
In particular, the proliferation rate and self-repair ability of chondrocytes in elderly patients are very low, which greatly limits the application of senile cartilage injury treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • In vitro telomere extension and proliferation culture method of chondrocytes and human tissue engineered regeneration of cartilage
  • In vitro telomere extension and proliferation culture method of chondrocytes and human tissue engineered regeneration of cartilage
  • In vitro telomere extension and proliferation culture method of chondrocytes and human tissue engineered regeneration of cartilage

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Example 1 Telomerase mRNA and complete medium to treat chondrocytes from elderly patients

[0050] 1. Telomerase mRNA must first be synthesized in vitro. Plasmid pBABE-neo-hTERT (plasmid 1774, Addgene, Cambridge, MA, USA) was amplified by PCR (primers were SEQ ID No.2 and SEQ ID No.3), and the TERT CDS region containing telomerase was amplified DNA (SEQ ID No.4). Then the 3'UTR (SEQ ID No.5) and 5'UTR (SEQ ID No.6) were amplified from human genomic DNA, and the polyA-containing sequence (SEQ ID No.7) was synthesized from the whole sequence, using overlapping PCR Methods All of them were connected to the DNA of the TERT CDS region to form a fragment: 5'UTR-TERT CDS-3'UTR-sequence containing polyA. Then, the fragment was double-digested with restriction endonucleases EcoR1 and SalI and ligated to the same digested plasmid Pcmv6-XL4. The telomerase plasmids with the correct sequence verified by sequencing, the target gene fragments in these plasmids are linearized by en...

Embodiment 2

[0054] Example 2 Detection of chondrocyte proliferation, telomerase activity, telomere length and cell metabolism after treatment with telomerase mRNA and complete medium

[0055] In this example, 4 groups of experiments are set up, namely control, hTERT, Compound and hTERT+compound, wherein control represents cells without any treatment, using basal medium (DMEM / F12 (Hyclone) + 5% human AB serum (Innovative)) Culture; hTERT represents cells transfected with telomerase mRNA, cultured in basal medium; Compound represents cells not transfected with telomerase mRNA, cultured in complete medium supplemented with various small molecule compounds; hTERT+compound represents cells Transfect telomerase mRNA and culture in complete medium. The primary chondrocytes were the zeroth generation, and at the third generation, the cells were planted in the wells of a 6-well plate, with 20,000 P3 generation chondrocytes per well.

[0056] When the cell density reaches nearly 100%, digest the c...

Embodiment 3

[0063] Example 3 Assembly of human tissue engineered regenerated cartilage

[0064] After the chondrocytes of elderly patients treated with telomerase mRNA and cultured in the complete medium containing various small molecular compounds are expanded to a sufficient number and in good growth state, it is necessary to prepare cell suspensions on collagen membrane scaffolds. After assembly and compounding, when the chondrocytes are completely attached to the collagen membrane, the finished human tissue engineered regenerated cartilage is made and transported to the hospital for treatment.

[0065] Firstly, AM medium (DMEM / F12 (Hyclone)+10% patient's autologous serum) was prepared. The cultured chondrocytes were taken for cell digestion, digested with 0.05% trypsin at 37°C for 5 min, and added complete medium to terminate the digestion. Centrifuge at 300g for 5 minutes at room temperature, resuspend the cells in AM medium, and count the cells. Centrifuge at 1500rpm for 5min, rem...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
Login to View More

Abstract

The invention discloses a method for lengthening, proliferating and culturing in-vitro telomeres of cartilage cells and human tissue engineering regenerated cartilage. The method and the human tissue engineering regenerated cartilage have the advantages that telomerase mRNA [(messenger RNA (ribonucleic acid)) transfection is carried out on the cartilage cells in an in-vitro manner, accordingly, the telomeres in cartilage cells obtained by means of culturing in follow-up procedures can be lengthened, proliferation and the viability of the cartilage cells and cartilage cells of elderly patients in particular can be obviously improved by the aid of synergistic effects of the telomerase mRNA transfection and small molecule compounds such as vitamin C, B18R or p65i, rapamycin and resveratrol in complete media, and the method and the human tissue engineering regenerated cartilage have important significance in improving or treating cell function decline due to senescence when the actually applied to regeneration medical treatment; the telomeres of the cartilage cells are not continuously or even frequently lengthened by the aid of the method for lengthening, proliferating and culturing the in-vitro telomeres of the cartilage cells, accordingly, genome insertion mutation risks or cell immortalization tumor formation risks can be prevented, the safety and the applicability can be greatly improved, and the method and the human tissue engineering regenerated cartilage can be effectively applied to the regeneration medical treatment.

Description

technical field [0001] The invention relates to the field of cell biology, in particular to a method for chondrocyte telomere prolongation and proliferation culture in vitro and human tissue engineered regeneration cartilage. Background technique [0002] Telomeres are protective caps at the ends of chromosomes, which are special structures composed of short, repeated non-transcribed sequences (TTAGGG) and some binding proteins, which can protect the stability of the genome and prevent the loss of genetic material at the ends of chromosomes. Cell expansion progressively affects telomere length. When the telomere is shortened to a certain extent, its protection will disappear, which will cause cell aging and apoptosis. [0003] Telomerase is the enzyme that synthesizes telomeres and maintains their length. Telomerase consists of two parts, an RNA template subunit, the telomerase mRNA component, and a protein catalytic unit, the telomerase reverse transcriptase. Not all bod...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/10C12N15/54A61L27/38A61L27/24
CPCA61L27/24A61L27/3817A61L27/3852A61L2430/06C12N5/0655C12N9/1276C12N2500/35C12N2500/38C12N2510/00C12Y207/07049
Inventor 吴海涛
Owner BEIHAO STEM CELL & REGENERATIVE MEDICINE RES INST CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com